AIRO Group AIRO 深 沪
等待开盘 08-21 09:30:00 美东时间
8.20
-0.390
-4.54%
华盛通- 最 高8.5866
- 今 开8.51
- 成交量 23.41万股
- 最 低 8.07
- 昨 收 8.59
- 总市值 2.59亿
- 52周最高 22.50
- 市盈率 静 --
- 换手率 0.74%
- 52周最低 5.71
- 委 比 83.33%
- 总股本 3155.59万
- 历史最高 39.07
- 量 比 0.22
- 振 幅 6.01%
- 历史最低 5.71
- 每 手 1
- 风险率 4.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | XChange飙升348%，拟收购智能体公司加速AI保险转型；ARX劲升43％
XChange飙升348%，拟收购智能体公司加速AI保险转型；ARX劲升43％，获私募溢价近5成收购；奥麦罗制药升逾26%，Q2业绩强劲，EPS扭亏为盈大超预期>>
08-14 16:05
AIRO Group surges 21% after returning to profit in Q2
AIRO Group (AIRO) shares were soaring over 21% on Thursday following strong second-quarter results, returning to profitability. Shares of the aerospace and defence firm advanced 21.44% to $10.31 durin...
08-13 23:52
AIRO Group Holdings Q2 EPS $(0.06) Beats $(0.29) Estimate, Sales $43.180M Beat $31.212M Estimate
AIRO Group Holdings (NASDAQ:AIRO) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.29) by 79.31 percent. This is a 120 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $43.180 mill...
08-13 18:30
AIRO Group Holdings Affirms FY2026 Sales Guidance of $104.543M-$113.634M vs $114.305M Est
AIRO Group Holdings (NASDAQ:AIRO) affirms FY2026 sales outlook from $104.543 million-$113.634 million to $104.543 million-$113.634 million vs $114.305 million estimate.
08-13 18:30
AIRO Q2 2026 Earnings: Drone Mix Lifts Gross Margin to 64%
AIRO Group Holdings’ Q2 2026 revenue rose 76% to $43.2 million, while diluted EPS moved to a $0.06 loss from $0.30 of earnings a year earlier. A favorable shift toward higher-margin drone products lifted gross margin to 64% and returned the company to operating profitability, even as GAAP net income turned negative because prior-year other-income benefits did not recur and current tax expense exceeded pretax income. AIRO also reiterated its full-
08-13 10:42
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Mizuho Maintains Outperform on AIRO Group Holdings, Lowers Price Target to $13
Mizuho analyst Brett Linzey maintains AIRO Group Holdings (NASDAQ:AIRO) with a Outperform and lowers the price target from $16 to $13.
07-21 20:49
AIRO完成搭载Zentra相机系统的首次运营交付
AIRO Group Holdings， Inc．宣布，已在2026年第二季度完成一批无人机系统订单的交付，标志着其新型Zentra相机系统首次在RQ-3...
07-09 23:57
AeroVironment's Q4 Blowout Triggers Drone Stock Melt-Up
AeroVironment Inc. (NASDAQ:AVAV) has triggered a sector‑wide melt‑up in drone tech stocks on Tuesday after a fourth‑quarter earnings beat that dramatically reset expectations for unmanned systems as a high‑growth defense theme. AVAV stock is soaring after the print. See the chart and price action h...
07-01 01:10
